Literature DB >> 12429512

Passive transfer of virus-specific antibodies confers protection against reproductive failure induced by a virulent strain of porcine reproductive and respiratory syndrome virus and establishes sterilizing immunity.

F A Osorio1, J A Galeota, E Nelson, B Brodersen, A Doster, R Wills, F Zuckermann, W W Laegreid.   

Abstract

Immune mechanisms mediating protective immunity against porcine reproductive and respiratory syndrome virus (PRRSV) are not well understood. The PRRSV-specific humoral immune response has been dismissed as being ineffective and perhaps deleterious for the host. The function of PRRSV antibodies in protective immunity against infection with a highly abortifacient strain of this virus was examined by passive transfer experiments in pregnant swine. All of a group of pregnant gilts (n = 6) that received PRRSV immunoglobulin (Ig) from PRRSV-convalescent, hyperimmune animals were fully protected from reproductive failure as judged by 95% viability of offspring at weaning (15 days of age). On the other hand, the totality of animals in a matched control group (n = 6) receiving anti-pseudorabies virus (PRV) Ig exhibited marked reproductive failure with 4% survival at weaning. Besides protecting the pregnant females from clinical reproductive disease, the passive transfer of PRRSV Ig prevented the challenge virus from infecting the dams and precluded its vertical transmission, as evidenced by the complete absence of infectious PRRSV from the tissues of the dams and lack of infection in their offspring. In summary, these results indicate that PRRSV-Igs are capable of conferring protective immunity against PRRSV and furthermore that these Igs can provide sterilizing immunity in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12429512     DOI: 10.1006/viro.2002.1612

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  79 in total

1.  The presence of alpha interferon at the time of infection alters the innate and adaptive immune responses to porcine reproductive and respiratory syndrome virus.

Authors:  Susan L Brockmeier; Crystal L Loving; Eric A Nelson; Laura C Miller; Tracy L Nicholson; Karen B Register; Marvin J Grubman; Douglas E Brough; Marcus E Kehrli
Journal:  Clin Vaccine Immunol       Date:  2012-02-01

2.  Development of a chimeric strain of porcine reproductive and respiratory syndrome virus with an infectious clone and a Korean dominant field strain.

Authors:  Jung-Ah Lee; Nak-Hyung Lee; Sang-Won Lee; Seung-Yong Park; Chang-Seon Song; In-Soo Choi; Joong-Bok Lee
Journal:  J Microbiol       Date:  2014-03-29       Impact factor: 3.422

3.  Porcine reproductive and respiratory syndrome virus neutralizing antibodies provide in vivo cross-protection to PRRSV1 and PRRSV2 viral challenge.

Authors:  Sally R Robinson; Michael C Rahe; Diem K Gray; Kyra V Martins; Michael P Murtaugh
Journal:  Virus Res       Date:  2018-02-03       Impact factor: 3.303

4.  Exosomes Mediate Intercellular Transmission of Porcine Reproductive and Respiratory Syndrome Virus.

Authors:  Ting Wang; Liurong Fang; Fuwei Zhao; Dang Wang; Shaobo Xiao
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

5.  Safety and efficacy of a novel European vaccine for porcine reproductive and respiratory virus in bred gilts.

Authors:  Michael D Piontkowski; Jeremy Kroll; Francois-Xavier Orveillon; Christian Kraft; Teresa Coll
Journal:  Can J Vet Res       Date:  2016-10       Impact factor: 1.310

6.  Protection against porcine reproductive and respiratory syndrome virus (PRRSV) infection through passive transfer of PRRSV-neutralizing antibodies is dose dependent.

Authors:  O J Lopez; M F Oliveira; E Alvarez Garcia; B J Kwon; A Doster; F A Osorio
Journal:  Clin Vaccine Immunol       Date:  2007-01-10

7.  A single amino acid deletion in the matrix protein of porcine reproductive and respiratory syndrome virus confers resistance to a polyclonal swine antibody with broadly neutralizing activity.

Authors:  Benjamin R Trible; Luca N Popescu; Nicholas Monday; Jay G Calvert; Raymond R R Rowland
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

8.  Protective humoral immune response induced by an inactivated porcine reproductive and respiratory syndrome virus expressing the hypo-glycosylated glycoprotein 5.

Authors:  Jung-Ah Lee; Byungjoon Kwon; Fernando A Osorio; Asit K Pattnaik; Nak-Hyung Lee; Sang-Won Lee; Seung-Yong Park; Chang-Seon Song; In-Soo Choi; Joong-Bok Lee
Journal:  Vaccine       Date:  2014-05-09       Impact factor: 3.641

9.  Attenuation of porcine reproductive and respiratory syndrome virus by molecular breeding of virus envelope genes from genetically divergent strains.

Authors:  Yan-Yan Ni; Tanja Opriessnig; Lei Zhou; Dianjun Cao; Yao-Wei Huang; Patrick G Halbur; Xiang-Jin Meng
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

10.  Use of an experimental model to test the efficacy of planned exposure to live porcine reproductive and respiratory syndrome virus.

Authors:  Tanja Opriessnig; Rodney B Baker; Patrick G Halbur
Journal:  Clin Vaccine Immunol       Date:  2007-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.